6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
16m ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
48m ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
48m ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
48m ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
49m ago	First Quantum Minerals Reports First Quarter 2026 Results

About

Monopar Therapeutics Inc (NASDAQ:MNPR) — investor relations, events, news, and company updates on 6ix.

Latest News

Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026

Monopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update

Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer

Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments

Monopar Presents New Data and Analyses on Rapidly Improved Copper Balance in Wilson Disease Patients on Tiomolybdate Choline at AASLD - The Liver Meeting® 2025

Financials

Revenue

$0

Market Cap

$359.23 M

EPS

-1.85

Community Chat

Ask AI